We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
PURITAN MEDICAL

THERMO FISHER SCIENTIFIC

Thermo Fisher Scientific provides analytical instruments, lab equipment, specialty diagnostics, reagents and integrat... read more Featured Products: More products

Download Mobile App




Crohn's Disease-Associated Bacteria Tolerate Antibiotics

By LabMedica International staff writers
Posted on 26 Nov 2019
Print article
Image: Axio Vert.A1 inverted microscope (Photo courtesy of Carl Zeiss)
Image: Axio Vert.A1 inverted microscope (Photo courtesy of Carl Zeiss)
Crohn's disease is a chronic disease that causes inflammation and irritation in the digestive tract. The disease is characterized by an imbalance in the intestinal microbiome. In particular, adherent-invasive Escherichia coli (AIEC) strains have been implicated in the disease.

The diversity of virulence factors displayed by multiple AIEC strains suggests that members of this pathovar have evolved different strategies to colonize their hosts. AIEC ability to persist, and in some cases replicate within macrophages is particularly intriguing. A reference strain for this pathovar, AIEC LF82, forms micro-colonies within phagolysosomes, an environment that prevents commensal E. coli multiplication.

Microbiologists at the Université Paris Sciences et Lettres (Paris, France) and their associates used single-cell analysis, genetic dissection and mathematical models to monitor the growth status and cell cycle regulation of intracellular AIEC LF82. The investigators infected cells resulting in the observation of three LF82 bacteria per macrophage on average at 1 hour. Imaging was performed on an inverted Zeiss Axio Imager (Jena, Germany) with a spinning disk CSU W1 (Yokogawa, Tokyo, Japan).

The team also performed antibiotic challenge and viable bacterial count using the gentamycin protection assay, fluorescence quantification, live and dead assays using the Live and Dead BacLight Viability kit (Thermo Fisher Scientific, Waltham, MA, USA), measurement of gene expression by RT-qPCR using a MyiQ real-time qPCR machine (Bio-Rad, Hercules, CA, USA).

The scientists reported that they found that within macrophages, bacteria may replicate or undergo non-growing phenotypic switches. This switch results from stringent response firing immediately after uptake by macrophages or at later stages, following genotoxic damage and SOS induction during intracellular replication. Importantly, non-growers resist treatment with various antibiotics. Thus, intracellular challenges induce AIEC LF82 phenotypic heterogeneity and non-growing bacteria that could provide a reservoir for antibiotic-tolerant bacteria responsible for relapsing infections. Importantly, non-growers resist treatment with various antibiotics.

The authors concluded that intracellular challenges induce AIEC LF82 phenotypic heterogeneity and non-growing bacteria that could provide a reservoir for antibiotic-tolerant bacteria responsible for relapsing infections. The study was published on November 14, 2019 in the journal PLOS Pathogens.

Related Links:
Université Paris Sciences et Lettres
Carl Zeiss
Yokogawa
Thermo Fisher Scientific
Bio-Rad


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Specimen Collection & Transport
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Xylazine Immunoassay Test
Xylazine ELISA

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: The study showed the blood-based cancer screening test detects 83% of people with colorectal cancer with specificity of 90% (Photo courtesy of Guardant Health)

Blood Test Shows 83% Accuracy for Detecting Colorectal Cancer

Colorectal cancer is the second biggest cause of cancer deaths among adults in the U.S., with forecasts suggesting 53,010 people might die from it in 2024. While fewer older adults are dying from this... Read more

Hematology

view channel
Image: The Gazelle Hb Variant Test (Photo courtesy of Hemex Health)

First Affordable and Rapid Test for Beta Thalassemia Demonstrates 99% Diagnostic Accuracy

Hemoglobin disorders rank as some of the most prevalent monogenic diseases globally. Among various hemoglobin disorders, beta thalassemia, a hereditary blood disorder, affects about 1.5% of the world's... Read more

Industry

view channel
Image: These new assays are being developed for use on the recently introduced DxI 9000 Immunoassay Analyzer (Photo courtesy of Beckman Coulter)

Beckman Coulter and Fujirebio Expand Partnership on Neurodegenerative Disease Diagnostics

Beckman Coulter Diagnostics (Brea, CA, USA) and Fujirebio Diagnostics (Tokyo, Japan) have expanded their partnership focused on the development, manufacturing and clinical adoption of neurodegenerative... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.